ACTRN12621001528842
Recruiting
未知
Efficacy and safety of ureteric stents in patients who have recently undergone ureteroscopy for stone disease
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Royal North Shore Hospital
- Enrollment
- 180
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria
- •Patients undergoing elective ureteropyeloscopy and laser lithotripsy of renal or ureteric calculi who will have double J ureteric stents placed
- •Patients aged between 20\-70
- •Patients who are independent in their activities of daily living (ADLs)
Exclusion Criteria
- •Exclusion Criteria
- •Patients who had ureteric stents placed for non\-calculous disease – i.e. cancer, renal disease, ureteric stricture
- •Patients \<20 and \>70 years of age
- •Patients who are semi\-dependent or completely dependent in their ADLs (i.e. nursing home residents)
- •Patients who have physical difficulties which limit their ability in removing stents
- •Patients who have had stents left for \> 2 weeks prior to removal, which increases the risk of encrustation and therefore potential difficulty in removing the stent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Does a continuous low-dose antibiotic treatment lower the rates of urinary tract infections and stent related symptoms in patients with ureteral stents compared to a periinterventionel prophylaxis only?rinary tract infection (UTI)Ureteral stent related symptoms (SRS)Urinary tract infection (UTI)Renal and Urogenital - Other renal and urogenital disordersACTRN12612000002886Department of Urology, University Hospital Bern88
Not yet recruiting
Not Applicable
Education – Does it alter representations for Medical Care post Ureteric Stent Insertion?ACTRN12613000413729Dr Gideon Blecher150
Terminated
Not Applicable
Evaluation of Ureteral Stents in the Management of Stone DiseaseUrinary StonesUrinary Tract StonesNCT02211313Washington University School of Medicine41
Recruiting
Phase 4
Solifenacin to relieve ureteral stent-related symptoms:A randomized, double-blinded placebo-controlled studyreteral stent-related symptoms after ureteroscopic stone manipulation.Ureteral stent-related symptoms after ureteroscopic stone manipulation.Renal and Urogenital - Other renal and urogenital disordersACTRN12610001022055Mennonite Christian Hospital, Taiwan100
Recruiting
Not Applicable
Development of a New Canadian Endourology Group Stent Symptom ScoreUrologic DiseasesNCT04909541Centre hospitalier de l'Université de Montréal (CHUM)180